7 February 2024 – JCVI announced its advice regarding persons who will be eligible for a COVID-19 booster vaccine in spring 2024.

View JCVI advice regarding persons who will be eligible for a COVID-19 vaccination in Spring 2024 and considerations on future COVID-19 vaccination programmes beyond Spring 2024 (external website)

1 September - CMO Letter: Winter Programme 2023 – Seasonal Flu and COVID-19 Vaccination

View the CMO letter (external website).

8 August 2023 – COVID-19 booster vaccine in Autumn 2023

View JCVI advice regarding persons who will be eligible for a COVID-19 booster vaccine in autumn 2023 (external website).

11 May 2023 - 2023 Covid-19 programme for at-risk children 6 months to 4 years of age

View the CMO letter (external website).

14 March - CMO Letter: Spring COVID-19 programme 2023

View the CMO letter (external website).

22 February 2023 -

JCVI statement

setting out the advice from the Joint Committee on Vaccination and Immunisation (JCVI) on the spring 2023 COVID-19 vaccination programme.

View the JCVI statement (external website).

21 December - CMO letter with updated guidance to medical practitioners for death certification and reporting deaths to the procurator fiscal during the recovery from COVID-19 disease pandemic

View the CMO letter (external website).

29 November 2022 - CMO letter: Interleukin-6 inhibitors (tocilizumab or sarilumab) for adult patients hospitalised due to COVID-19

View the CMO letter (external website).

28 November 2022 - CMO letter: COVID-19 Therapeutic Alert: Treatments for Highest Risk Non-Hospitalised Patients (Adults and Children) with COVID-19

View the CMO letter (external website).

28 November 2022 - CMO letter: COVID-19 Therapeutic Alert: Treatment of Hospital-Onset COVID-19 In Adults and Children

View the CMO letter (external website).

28 November 2022 - CMO letter: COVID-19 Therapeutic Alert: Remdesivir for patients hospitalised due to COVID-19

View the CMO letter (external website).

28 November 2022 - CMO letter: COVID-19 Therapeutic Alert: Baricitinib for Patients Hospitalised Due to COVID-19 (Adults and Children Aged 2 Years and Over)

View the CMO letter (external website).

15 September 2022 - CMO Letter: Winter Vaccination Programme 2022 update - Seasonal Flu Immunisation and COVID-19 Boosters

View the CMO letter (external website).

14 September 2022 - CMO letter: Advance Notice of a Pause of Asymptomatic Staff Testing in Health and Social Care and Asymptomatic Testing in Hospitals to be in place by the end of September 2022.

View the CMO letter (external website).

25 August 2022 - CMO letter: Winter Vaccination Programme 2022 – Seasonal Flu Immunisation and Covid-19 Boosters

View the CMO letter (external website).

18 May 2022 - CMO letter: JCVI advice on additional booster doses for clinical trial participants

View the CMO letter (external website).

5 May 2022 – CMO letter: COVID-19 Therapeutic Alert: Baricitinib for patients hospitalised due to COVID-19 (adults and children aged 2 years and over)

View the CMO letter (external website).

25 April 2022 - CMO letter with update on Highest Risk List

View the CMO letter (external website).

19 April 2022 - CMO letter with updated guidance to medical practitioners for death certification and reporting deaths to the procurator fiscal during the covid-19 pandemic

View the CMO letter (external website).

4 March 2022 - CMO letter about deferral of fertility treatment for patients who are not vaccinated against COVID-19 review

View the CMO letter (external website).

28 February 2022 - Green Book - Chapter 14a has been updated to include spring booster recommendations and information about one-off programme for those aged 5 to 11 years

Find out more about this update on the Green Book vaccination guidance pages.

21 February 2022 - JCVI statement on COVID-19 vaccinations in 2022

View the JCVI statement on COVID-19 vaccinations in 2022.

16 February 2022 - JCVI statement update on advice for COVID-19 vaccination of children aged 5 to 11

View the JCVI statement (external website).

18 January 2022 - CMO letter about COVID-19 vaccination programme: further vaccination of children and young people

Find out more in the CMO letter (external website).

12 January 2022 - Green Book updated to include management of 5 to 11s who are about to become immunosuppressed and advice on third primary doses for severe immunosuppression

Learn more about this update on the Green Book vaccination guidance pages.

7 January 2022 - CMO letter about deferral of fertility treatment for patients who are not vaccinated against COVID-19

Find out more about the CMO letter (external website).

24 December 2021 - Green Book updated to include updated risk for pregnancy and JCVI advice on boosters for 16 and 17 and at risk 12 to 15 year olds

Find out more about this update on the Green Book vaccination guidance pages.

22 December 2021 - JCVI statement about COVID-19 vaccination of children and young people 

View the JCVI statement (external website).

14 December 2021 - Green Book updated to include JCVI advice on boosters for 16 and 17 and at risk 12 to 15 year olds, and primary immunisation for 5 to 11 year olds

Find out more about this update on the Green Book vaccination guidance pages.

1 December 2021 - CMO letter about COVID-19 vaccination programme: B.1.1.529 Variant (Omicron)

Find out more about the CMO letter (external website).

29 November 2021 - JCVI advice on the UK vaccine response to the Omicron variant

Find out more about the JCVI advice on the UK vaccine response to the Omicron variant (external website).

22 November 2021 - CMO letter about COVID-19 vaccination programme: JCVI, Green Book update, rolling programme vaccination offer

Find out more about the CMO letter (external website).

15 November 2021 - Green Book updated to include second doses for 16 to 17 year olds and booster doses for 40 to 49 year olds

Learn more about this update.

11 November 2021 - CMO letter about COVID-19 vaccination programme: JCVI advice on clinical trial participants

View the CMO letter about JCVI advice on clinical trial participants (external website).

5 November 2021 – Green Book updated to allow flexibility on dose timing for booster vaccinations

View the CMO letter about the Green Book update to allow operational flexibility on dose timing for booster vaccination (external website).

21 September 2021 – JCVI advice on the vaccination of severely immunosuppressed individuals

View the CMO letter about JCVI advice on the vaccination of severely immunosuppressed individuals (external website).

17 September 2021 – National policy on offering COVID-19 vaccinations to 12 to 15-year-olds

View the CMO letter about national policy on offering COVID-19 vaccinations to 12 to 15-year-olds (external website).

3 September 2021 – COVID-19 vaccination of children and young people aged 12 to 15 years

View JCVI statement on COVID-19 vaccination of children and young people aged 12 to 15 years on GOV.UK (external website).

September 2021 – Vaccine self-registration portal goes live

Learn more about the vaccine self-registration portal for all ages on NHS inform (external website).

23 August 2021 – Myocarditis and pericarditis information for healthcare professionals

View information for healthcare professionals on myocarditis and pericarditis following COVID-19 vaccination on GOV.UK (external website).

20 August 2021 – Guillain-Barré Syndrome information for healthcare professionals

View information about COVID-19 vaccination and Guillain-Barré Syndrome for healthcare professionals by UK HSA (formerly PHE) on GOV.UK (external website).

6 August 2021 – JCVI advice for vaccination of 16 and 17-year-olds

View the CMO letter about JCVI advice for vaccination of 16 and 17-year-olds (external website).

4 August 2021 – COVID-19 vaccination of children and young people aged 12 to 17 years

View JCVI statement on COVID-19 vaccination of children and young people aged 12 to 17 years on GOV.UK (external website).

7 July 2021 – Review of extremely rare reports of myocarditis and pericarditis

Learn more about the review of extremely rare reports of myocarditis and pericarditis by MHRA on GOV.UK (external website).

30 June 2021 – Booster vaccine programme winter 2021 to 2022

View JCVI interim advice on COVID-19 booster vaccine programme winter 2021 to 2022 on GOV.UK (external website).

20 June 2021 – Allergy Management and Patient Screening tools

View our workforce resources page for more information about these tools (external website).

18 May 2021 – B.1.617.2 Variant

View the CMO letter about the B.1.617.2 variant (external website).

7 May 2021 – Use of AstraZeneca vaccine

View JCVI statement on use of the AstraZeneca vaccine on GOV.UK (external website).

13 April 2021 – JCVI phase 2 update

View the JCVI update on phase 2 of the COVID-19 vaccination programme (external website).